Selected research
Industry Research
Point-of-Care Biosensors Industry Research Report 2026
Market perspective
The global Point-of-Care Biosensors market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Point-of-Care Biosensors is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Point-of-Care Biosensors is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Point-of-Care Biosensors is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Point-of-Care Biosensors include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Point-of-Care Biosensors market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Point-of-Care Biosensors.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Point-of-Care Biosensors Market by Company
Molecular Devices Corp.
Abbott Laboratories
QTL Biodetection LLC
Biosensors International Group
Nova Biomedical
Medtronic
Siemens Healthineers AG
Johnson & Johnson
LifeScan, Inc.
TDK Corporation
Molex LLC
Zimmer & Peacock AS
Koninklijke Philips N.V.
GE Healthcare
Bio-Rad Laboratories Inc.
Point-of-Care Biosensors Segment by Type
Thermal
Piezoelectric
Electrochemical
Optical
Point-of-Care Biosensors Segment by Application
Fertility/Pregnancy
Glucose Testing
Hb1Ac Testing
Infectious Disease
Cardiology and Oncology
Other
Point-of-Care Biosensors Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Biosensors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Biosensors and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Biosensors.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-of-Care Biosensors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-of-Care Biosensors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-of-Care Biosensors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Thermal
- Piezoelectric
- Electrochemical
- Optical
Applications
- Fertility/Pregnancy
- Glucose Testing
- Hb1Ac Testing
- Infectious Disease
- Cardiology and Oncology
- Other
Companies covered
- Molecular Devices Corp.
- Abbott Laboratories
- QTL Biodetection LLC
- Biosensors International Group
- Nova Biomedical
- Medtronic
- Siemens Healthineers AG
- Johnson & Johnson
- LifeScan, Inc.
- TDK Corporation
- Molex LLC
- Zimmer & Peacock AS
- Koninklijke Philips N.V.
- GE Healthcare
- Bio-Rad Laboratories Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Point-of-Care Biosensors by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Thermal
- 2.2.3 Piezoelectric
- 2.2.4 Electrochemical
- 2.2.5 Optical
- 2.3 Point-of-Care Biosensors by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Fertility/Pregnancy
- 2.3.3 Glucose Testing
- 2.3.4 Hb1Ac Testing
- 2.3.5 Infectious Disease
- 2.3.6 Cardiology and Oncology
- 2.3.7 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Point-of-Care Biosensors Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Point-of-Care Biosensors Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Point-of-Care Biosensors Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Point-of-Care Biosensors Production by Manufacturers (2021-2026)
- 3.2 Global Point-of-Care Biosensors Production Value by Manufacturers (2021-2026)
- 3.3 Global Point-of-Care Biosensors Average Price by Manufacturers (2021-2026)
- 3.4 Global Point-of-Care Biosensors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Point-of-Care Biosensors Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Point-of-Care Biosensors Manufacturers, Product Type & Application
- 3.7 Global Point-of-Care Biosensors Manufacturers Established Date
- 3.8 Global Point-of-Care Biosensors Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Molecular Devices Corp.
- 4.1.1 Molecular Devices Corp. Point-of-Care Biosensors Company Information
- 4.1.2 Molecular Devices Corp. Point-of-Care Biosensors Business Overview
- 4.1.3 Molecular Devices Corp. Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.1.4 Molecular Devices Corp. Product Portfolio
- 4.1.5 Molecular Devices Corp. Recent Developments
- 4.2 Abbott Laboratories
- 4.2.1 Abbott Laboratories Point-of-Care Biosensors Company Information
- 4.2.2 Abbott Laboratories Point-of-Care Biosensors Business Overview
- 4.2.3 Abbott Laboratories Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.2.4 Abbott Laboratories Product Portfolio
- 4.2.5 Abbott Laboratories Recent Developments
- 4.3 QTL Biodetection LLC
- 4.3.1 QTL Biodetection LLC Point-of-Care Biosensors Company Information
- 4.3.2 QTL Biodetection LLC Point-of-Care Biosensors Business Overview
- 4.3.3 QTL Biodetection LLC Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.3.4 QTL Biodetection LLC Product Portfolio
- 4.3.5 QTL Biodetection LLC Recent Developments
- 4.4 Biosensors International Group
- 4.4.1 Biosensors International Group Point-of-Care Biosensors Company Information
- 4.4.2 Biosensors International Group Point-of-Care Biosensors Business Overview
- 4.4.3 Biosensors International Group Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.4.4 Biosensors International Group Product Portfolio
- 4.4.5 Biosensors International Group Recent Developments
- 4.5 Nova Biomedical
- 4.5.1 Nova Biomedical Point-of-Care Biosensors Company Information
- 4.5.2 Nova Biomedical Point-of-Care Biosensors Business Overview
- 4.5.3 Nova Biomedical Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.5.4 Nova Biomedical Product Portfolio
- 4.5.5 Nova Biomedical Recent Developments
- 4.6 Medtronic
- 4.6.1 Medtronic Point-of-Care Biosensors Company Information
- 4.6.2 Medtronic Point-of-Care Biosensors Business Overview
- 4.6.3 Medtronic Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.6.4 Medtronic Product Portfolio
- 4.6.5 Medtronic Recent Developments
- 4.7 Siemens Healthineers AG
- 4.7.1 Siemens Healthineers AG Point-of-Care Biosensors Company Information
- 4.7.2 Siemens Healthineers AG Point-of-Care Biosensors Business Overview
- 4.7.3 Siemens Healthineers AG Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.7.4 Siemens Healthineers AG Product Portfolio
- 4.7.5 Siemens Healthineers AG Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Point-of-Care Biosensors Company Information
- 4.8.2 Johnson & Johnson Point-of-Care Biosensors Business Overview
- 4.8.3 Johnson & Johnson Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 LifeScan, Inc.
- 4.9.1 LifeScan, Inc. Point-of-Care Biosensors Company Information
- 4.9.2 LifeScan, Inc. Point-of-Care Biosensors Business Overview
- 4.9.3 LifeScan, Inc. Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.9.4 LifeScan, Inc. Product Portfolio
- 4.9.5 LifeScan, Inc. Recent Developments
- 4.10 TDK Corporation
- 4.10.1 TDK Corporation Point-of-Care Biosensors Company Information
- 4.10.2 TDK Corporation Point-of-Care Biosensors Business Overview
- 4.10.3 TDK Corporation Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.10.4 TDK Corporation Product Portfolio
- 4.10.5 TDK Corporation Recent Developments
- 4.11 Molex LLC
- 4.11.1 Molex LLC Point-of-Care Biosensors Company Information
- 4.11.2 Molex LLC Point-of-Care Biosensors Business Overview
- 4.11.3 Molex LLC Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.11.4 Molex LLC Product Portfolio
- 4.11.5 Molex LLC Recent Developments
- 4.12 Zimmer & Peacock AS
- 4.12.1 Zimmer & Peacock AS Point-of-Care Biosensors Company Information
- 4.12.2 Zimmer & Peacock AS Point-of-Care Biosensors Business Overview
- 4.12.3 Zimmer & Peacock AS Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.12.4 Zimmer & Peacock AS Product Portfolio
- 4.12.5 Zimmer & Peacock AS Recent Developments
- 4.13 Koninklijke Philips N.V.
- 4.13.1 Koninklijke Philips N.V. Point-of-Care Biosensors Company Information
- 4.13.2 Koninklijke Philips N.V. Point-of-Care Biosensors Business Overview
- 4.13.3 Koninklijke Philips N.V. Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.13.4 Koninklijke Philips N.V. Product Portfolio
- 4.13.5 Koninklijke Philips N.V. Recent Developments
- 4.14 GE Healthcare
- 4.14.1 GE Healthcare Point-of-Care Biosensors Company Information
- 4.14.2 GE Healthcare Point-of-Care Biosensors Business Overview
- 4.14.3 GE Healthcare Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.14.4 GE Healthcare Product Portfolio
- 4.14.5 GE Healthcare Recent Developments
- 4.15 Bio-Rad Laboratories Inc.
- 4.15.1 Bio-Rad Laboratories Inc. Point-of-Care Biosensors Company Information
- 4.15.2 Bio-Rad Laboratories Inc. Point-of-Care Biosensors Business Overview
- 4.15.3 Bio-Rad Laboratories Inc. Point-of-Care Biosensors Production, Value and Gross Margin (2021-2026)
- 4.15.4 Bio-Rad Laboratories Inc. Product Portfolio
- 4.15.5 Bio-Rad Laboratories Inc. Recent Developments
5 Global Point-of-Care Biosensors Production by Region
- 5.1 Global Point-of-Care Biosensors Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Point-of-Care Biosensors Production by Region: 2021-2032
- 5.2.1 Global Point-of-Care Biosensors Production by Region: 2021-2026
- 5.2.2 Global Point-of-Care Biosensors Production Forecast by Region (2027-2032)
- 5.3 Global Point-of-Care Biosensors Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Point-of-Care Biosensors Production Value by Region: 2021-2032
- 5.4.1 Global Point-of-Care Biosensors Production Value by Region: 2021-2026
- 5.4.2 Global Point-of-Care Biosensors Production Value Forecast by Region (2027-2032)
- 5.5 Global Point-of-Care Biosensors Market Price Analysis by Region (2021-2026)
- 5.6 Global Point-of-Care Biosensors Production and Value, YOY Growth
- 5.6.1 North America Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Point-of-Care Biosensors Production Value Estimates and Forecasts (2021-2032)
6 Global Point-of-Care Biosensors Consumption by Region
- 6.1 Global Point-of-Care Biosensors Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Point-of-Care Biosensors Consumption by Region (2021-2032)
- 6.2.1 Global Point-of-Care Biosensors Consumption by Region: 2021-2026
- 6.2.2 Global Point-of-Care Biosensors Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Point-of-Care Biosensors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Point-of-Care Biosensors Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Point-of-Care Biosensors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Point-of-Care Biosensors Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Point-of-Care Biosensors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Point-of-Care Biosensors Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Point-of-Care Biosensors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Point-of-Care Biosensors Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Point-of-Care Biosensors Production by Type (2021-2032)
- 7.1.1 Global Point-of-Care Biosensors Production by Type (2021-2032) & (k units)
- 7.1.2 Global Point-of-Care Biosensors Production Market Share by Type (2021-2032)
- 7.2 Global Point-of-Care Biosensors Production Value by Type (2021-2032)
- 7.2.1 Global Point-of-Care Biosensors Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Point-of-Care Biosensors Production Value Market Share by Type (2021-2032)
- 7.3 Global Point-of-Care Biosensors Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Point-of-Care Biosensors Production by Application (2021-2032)
- 8.1.1 Global Point-of-Care Biosensors Production by Application (2021-2032) & (k units)
- 8.1.2 Global Point-of-Care Biosensors Production Market Share by Application (2021-2032)
- 8.2 Global Point-of-Care Biosensors Production Value by Application (2021-2032)
- 8.2.1 Global Point-of-Care Biosensors Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Point-of-Care Biosensors Production Value Market Share by Application (2021-2032)
- 8.3 Global Point-of-Care Biosensors Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Point-of-Care Biosensors Value Chain Analysis
- 9.1.1 Point-of-Care Biosensors Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Point-of-Care Biosensors Production Mode & Process
- 9.2 Point-of-Care Biosensors Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Point-of-Care Biosensors Distributors
- 9.2.3 Point-of-Care Biosensors Customers
10 Global Point-of-Care Biosensors Analyzing Market Dynamics
- 10.1 Point-of-Care Biosensors Industry Trends
- 10.2 Point-of-Care Biosensors Industry Drivers
- 10.3 Point-of-Care Biosensors Industry Opportunities and Challenges
- 10.4 Point-of-Care Biosensors Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst